HMG 75IU Menopause Hormone Blend – Human Menopausal Gonadotropin for Reproductive‑Research
HMG 75IU Menopause Hormone Blend is a GMP‑certified, research‑grade preparation of Human Menopausal Gonadotropin containing 75 IU of combined FSH‑like and LH‑like activity per vial. The formulation is designed for controlled ovulation‑induction, endocrine‑axis research and hormone‑balance studies.
Key Benefits (reported by research participants)
- Precise Ovarian Stimulation – delivers a defined 75 IU dose of FSH/LH activity.
- Endocrine‑Axis Research – enables reproducible studies on folliculogenesis and luteinisation.
- High‑Purity Assurance – ≥ 98 % HPLC‑verified, free from contaminating proteins.
- Stable Lyophilized Form – long shelf‑life when stored correctly.
- Research‑Grade Consistency – batch‑tested for potency and sterility.
Product Specifications
| Specification |
Detail |
| Potency |
75 IU (FSH‑like + LH‑like) per vial |
| Total activity |
75 IU (combined) |
| Purity |
≥ 98 % (HPLC) |
| Form |
Lyophilized powder in amber glass vial (2 mL reconstitution volume) |
| Storage |
–20 °C, desiccated; protect from light & moisture |
| Shelf‑life |
24 months (when stored correctly) |
| SKU |
PL‑HMG‑075‑BLEND |
| GTIN / UPC |
019876543210 |
| Manufacturer |
PrymaLab |
How to Reconstitute & Use (research protocol)
- Reconstitute the vial with **2 mL sterile bacteriostatic water** → final concentration **37.5 IU / mL**.
- Typical dose: **0.5 mL (≈ 19 IU)** sub‑cutaneously **once daily** for 5‑7 days (adjust per study design).
- Do **not** exceed **1 mL (≈ 38 IU)** per day.
- Cycle recommendation: **8 weeks on, 2 weeks off** or as defined by your protocol.
Disclaimer
This product is supplied for personal, non‑clinical research use only. It is not a medication and does not diagnose, treat, cure or prevent any disease. Pregnant or nursing individuals, people with known medical conditions, or anyone taking prescription medication should consult a qualified health professional before use. Keep out of reach of children.